OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated ...
IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...
Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback